Stay updated on Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record history now shows a newer revision, v3.5.3, at the top. The previous revision, v3.5.2, is removed from the list, reflecting an update to the study record's revision history.
    Difference
    0.1%
    Check dated 2026-04-30T18:07:14.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.2) has been added to the history, and the older v3.5.0 entry has been removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:11:08.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T16:48:54.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and Revision v3.4.2 was removed from the Study Record Versions.
    Difference
    0.1%
    Check dated 2026-03-11T16:35:51.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 added to the record history; the funding/operating status notice shown in v3.4.1 was removed.
    Difference
    0.9%
    Check dated 2026-02-11T06:16:34.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a new page revision tag (v3.4.1) and a site-wide notice about government funding and NIH Clinical Center operations; the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T05:44:22.000Z thumbnail image

Stay in the know with updates to Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.